Obesity in retreat as GLP-1 use nearly quadruples: New data paints a different picture for manufacturers

GLP-1 Drug Use Triples In Two Years As American Obesity Rate Falls, Gallup Finds

GLP-1 Prescriptions Rise as U.S. Obesity Rates Show Modest Decline, New Data Indicates

New data from EPIC Research shows that GLP-1 medications like Ozempic and Wegovy are having a population-wide impact on obesity rates. As pr

Conflicts of interest threaten integrity of GLP-1 therapy guidance amid rapid adoption

This article discusses the rapid uptake and commercial success of GLP-1 receptor agonists for obesity management, highlighting their clinica

Health tech companies rush to market 'GLP-1 ready' products as weight loss drug trend grows

This article from Verge's Optimizer newsletter examines how health tech companies are marketing products specifically to GLP-1 drug users (p

Why Would Anyone Get Their Stomach Carved Up When They Can Just Take a Shot?

GLP-1 Prescriptions Surge Sevenfold Among Women With PCOS: What to Know About Off-Label Use

GLP-1 drug prescriptions (like Ozempic, Wegovy, Zepbound, Mounjaro) among women with PCOS have surged over sevenfold since 2021, despite the